Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v3.8.0.1
Condensed Balance Sheet - USD ($)
Mar. 31, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 6,298,296 $ 8,899,154
Marketable securities 14,884,544 17,931,941
Prepaid expenses and other current assets 1,231,265 1,304,541
Total Current Assets 22,414,105 28,135,636
Security Deposits 30,785 30,785
Equipment, Net 109,380 121,460
Total Assets 22,554,270 28,287,881
Current Liabilities:    
Accounts payable and accrued expenses 3,049,021 3,233,926
Deferred Research and Development Arrangement   375,000
Other Liabilities 48,150 56,724
Warrant Liabilities 4,487,139 7,853,635
Total Liabilities 7,584,310 11,519,285
Commitments and Contingencies (note 14)
Stockholders' Equity:    
Preferred stock, par value $0.0001, 10,000,000 authorized shares, none issued and outstanding
Common stock, par value $0.0001, 50,000,000 authorized shares, 31,744,439 and 31,725,114 issued and outstanding 3,174 3,173
Additional paid-in capital 157,449,747 157,141,021
Accumulated other comprehensive loss (89,376) (56,886)
Accumulated deficit (142,393,585) (140,318,712)
Total Stockholders' Equity 14,969,960 16,768,596
Total Liabilities and Stockholders' Equity $ 22,554,270 $ 28,287,881